Public company info - Hansoh Pharmaceutical Group Company Limited , 03692.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Hansoh Pharmaceutical Group Company Limited, 03692.HK - Cash Flow 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities 3,871,086 2,378,419 1,633,456 1,557,847
Net Cash Flow from Return on Investments & Servicing of Finance -1,392,473 8 -404,132 -2,371,922
　Interest Received 107,527 0 0 0
　Interest Paid 0 0 0 -3,417
　Dividend Received 0 8 2 2
　Dividend Paid -1,500,000 0 -404,134 -2,368,507
　Others 0 0 0 0
Taxes (Paid) / Refunded -541,397 -306,192 -231,204 -311,340
Net Cash Flow from Investing Activities -7,183,126 -1,388,752 -614,273 829,536
　Additions to Fixed Assets -592,476 -405,921 -256,346 -267,827
　Disposal of Fixed Assets 11,046 8,252 3,400 2,767
　Increase in Investments -3,801,872 -11,247,831 -4,744,742 -4,773,134
　Decrease in Investments 61,536 10,258,043 4,390,156 5,827,449
　Net Cash Flow with Related Parties 0 0 -326,341 -281,594
　Others -2,861,360 -1,295 319,600 321,875
Net Cash Flow before Financing Activities -5,245,910 683,483 383,847 -295,879
Net Cash Flow from Financing Activities 9,492,728 0 -326,341 323,366
　New Loans 0 0 0 400,000
　Loans Repayment -41,668 0 0 -450,000
　Fixed Income/Debt Instruments 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0
　Equity Financing 9,534,396 0 0 1,302,449
　Net Cash Flow with Related Parties 0 0 -326,341 -281,594
　Others 0 0 0 -647,489
Increase(Decrease) in Cash & Cash Equivalents 4,246,818 683,483 57,506 27,487
Cash & Cash Equivalents at Beginning of Year 964,831 266,444 208,699 161,192
Net Cash Flow due to Change in Exchange Rate/Others 133,210 14,904 239 20,020
Cash & Cash Equivalents at End of Year 5,344,859 964,831 266,444 208,699
Currency Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved